Limited Time Offer Proprietary Research, Portfolio Monitoring, Investment Tools, and More.

MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock ideas, best-in-class research tools, real-time alerts, proprietary research reports, and much more.

$39.99 $19.99/month

For the first year, new members only.

Start Your 30-Day Free Trial

a couple facing laptop and staring at it

Top Premium Features All Access is Robust and Reliable

Top-Rated Stocks

Discover stocks with our top-rated stock lists, showcasing top recommendations from Wall Street's best-performing and most accurate research analysts.

Trending Stocks

Our trending stock tools monitor social media chatter and news sentiment in real-time to help identify hot stocks before you hear about them on the news.

The Idea Engine™

Powered by over 24 algorithmic factors and technical indicators, new Idea Engine™ stock ideas are released at the start of each week.

Proprietary Reports

Stay ahead of the curve with exclusive research reports about emerging industries and market trends, crafted by our expert analysts and reserved solely for All Access subscribers.

Stocks to Short

Pinpoint stocks recently affected by negative news or technical indicators - a helpful starting point for investors to identify potential risks or opportunities.

Portfolio Monitoring

All Access offers comprehensive portfolio monitoring and highly customizable real-time alerts, ensuring you stay informed about your stocks' performance and breaking news via email or SMS.

More All Access Benefits

Momentum Alerts
Live News Feed
Exclusive Stock Articles
Short Trading Ideas
Earnings Calls and Transcripts
Dividend Stock Ideas

Performance Ratings for Wall Street Analysts
1 Million+ Historical Analyst Ratings and Price Targets
Sector Performance Maps
Stock and ETF Screeners
Stock Comparison Tools

Media Sentiment Analysis Tools
Extended CSV/Excel Data Export Tools
Premium Newsletters
Priority Newsletter Delivery
Premium Customer Support
No Ads on MarketBeat.com

Start Your 30-Day Free Trial

Top Stock Ideas Your Ultimate Investment Research Toolkit

No matter what your investment strategy, MarketBeat All Access will help you find companies with the ingredients to outperform the market. Your subscription includes a suite of screeners and tools that help you easily search and identify stocks that align with your investment strategy.

6 Stock Screeners
75+ Technical Filters
12+ Industry Reports
15+ Exclusive Stock Lists
Unlimited Stocks in Your Watchlist

Start Your 30-Day Free Trial

Your Success is Our Success Take The Guesswork out of Investing

We believe that successful investing shouldn't be complicated, which is why MarketBeat All Access simplifies stock selection for our members by regularly providing new ideas and insights.

As a subscriber, you'll immediately receive our top stock ideas enabling you to spend less time navigating the complexities of the market and more time doing what you love.

Start Your 30-Day Free Trial

MarketBeat All Access on desktop and phone devices

Stock Ideas from The Idea Engine™

BMRN BioMarin Pharmaceutical

down 16.59% 90 days after 2/25/2025

The MarketBeat Idea Engine™ identified BioMarin Pharmaceutical as having momentum on 2/25/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $69.00 at the time of the recommendation. After 90 days, the stock was trading at $57.55, representing a -16.59% ROI. The current price for BMRN is $58.09.

AKAM Akamai Technologies

down 1.16% 90 days after 2/24/2025

The MarketBeat Idea Engine™ identified Akamai Technologies as having a strong negative sentiment on 2/24/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $76.73 at the time of the recommendation. After 90 days, the stock was trading at $75.84, representing a -1.16% ROI. The current price for AKAM is $76.42.

BKNG Booking

up 6.89% 90 days after 2/24/2025

The MarketBeat Idea Engine™ identified Booking as having a strong positive sentiment on 2/24/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $4,989.22 at the time of the recommendation. After 90 days, the stock was trading at $5,332.80, representing a 6.89% ROI. The current price for BKNG is $5,475.26.

BRZE Braze

down 12.19% 90 days after 2/24/2025

The MarketBeat Idea Engine™ identified Braze as having a strong negative sentiment on 2/24/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $39.55 at the time of the recommendation. After 90 days, the stock was trading at $34.73, representing a -12.19% ROI. The current price for BRZE is $36.07.

FANG Diamondback Energy

down 12.98% 90 days after 2/24/2025

The MarketBeat Idea Engine™ identified Diamondback Energy as having a strong positive sentiment on 2/24/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $156.12 at the time of the recommendation. After 90 days, the stock was trading at $135.86, representing a -12.98% ROI. The current price for FANG is $136.28.

Trusted By Many All Access Empowers Individual Investors

Invaluable and Timely “I have been with the same major brokerage company for the last 49 years and MarketBeat is the only program that makes it easy and concise to manage several of my clients portfolios.MarketBeat is the only company, to my knowledge, that gives me invaluable and timely source of information on all my holdings. I am now able to make meaningful investment decisions.”

— Peter T.

MarketBeat is the Best of the Best Invesment Tool “I have subscribed to tens of investment newsletters, watchlist, Dow and S&P suggested stocks and funds to own. Marketbeat is by far the most informative, action packed investment research tool I have ever subscribed.”

— Nick

“Very good good information provider for stocks with useful features such as stock alerts, analyst rankings and screening capabilities. There is a steady flow of new features and improvements. Highly responsive customer service if ever you need some attention.”

— Robin M.

“I've been a customer of MarketBeat for a year now and have been extremely pleased with the quality and timeliness of their data and research. It is one of my "must have" resources that I depend on as we navigate the markets and manage our client's volatility.”

— Tom S.

Everything in One Place “Good value for the money with a "one stop shopping" approach. Customizable home page, article notifications, charts, current price and 52 week range to name a few. Has everything in one place.”

— Daryll S.

I used to spend hours... “I used to spend hours gathering/interpreting the info I needed to manage my modest stock investments. MarketBeat lets me do those things in minutes. Well worth the investment!”

— Mike D.

Excellent Valuable Investor Tool. “I have [had] a very good experience with MarketBeat. It has a wealth of information that help me invest in the stock market. It helps me monitor my portfolio and alert me on the stocks that I am monitoring. It also gives me analysts' rating on the stocks. It has much much more. It is a very valuable tool for individual investor like me.”

— Hube S.

Consistent winning recommendations “The company consistently recommends stocks that work well with my budget and are frequently winners. Thank you very much for all that you do.”

— Eleanor

The analysis is broad-based “The data is current, insightful, and pertinent to my financial planning practice. I look forward to each daily market insight email!”

— Dale K.

Timely Market Facts Are Priceless “I feel empowered knowing that I have up to date Market perspectives presented in a plain talk format!”

— Lamar C.

MarketBeat All Access is used by enthusiastic beginners and professional traders from these firms and more:

10,578

All Access Subscribers

5,658,033

Community Members

96,150,558

Traders Per Year

Limited Time Offer You are only one step away from gaining access to world-class investing tools and research.

Get Your Discount to MarketBeat All Access Today!

Annual Billing

$399.00 $199.00/year

Save an additional $40.88 with annual billing!

Monthly Billing

$39.99 $19.99/month

Save 50%!

Experience MarketBeat All Access Risk-Free with Our 30-Day Free Trial

We're confident you'll discover the immense value of MarketBeat All Access during your free 30-day trial that we offer it with no strings attached. If you decide to cancel within the first 30 days, you can do so online with no questions asked.

Try it out – you have nothing to lose.

Start Your 30-Day Free Trial